symbol-DOD

DOD DOD BIOTECH PUBLIC COMPANY LIMITED

DOD
DOD BIOTECH PUBLIC COMPANY LIMITED
1.80
+0.06 (+3.45%)
High1.85
Low1.75
Total Vol3,216,200
Total Val(K)5,829.00
Description
DOD operates as a manufacturer of dietary supplement products under customers` brand

Overview


  • SymbolDOD
  • Market Cap (M.Bath)783.72
  • IPO Date20 Jun 2018
  • IPO Price9.30 @Par Value 0.50 Baht
  • CEOMrs. APAPORN KOSOLKUL
  • Employees-
  • IndustryCONSUMP-M
  • Sector-
  • IndexMAI
  • SET ESG Ratings-

สรุปภาพรวมตลาด

DOD BIOTECH PUBLIC COMPANY LIMITED
Websitewww.dodbiotech.com
AddressNo. 111 Moo 2 Tha Chin Sub-district, Mueang Samut Sakhon District Samut Sakhon 74000
Telephone0-3444-6333, 0-3444-6444
Fax0-3444-0373

Detail of Security

MarketMAI
First Trade Date20 Jun 2018
IndustryCONSUMP-M
Sector-
Foreign Limit (%)49.00 (Date 31 Mar 2026)
Foreign Ownership Limit Remaining (shares)220,696,898
Free Float (%)60.73
Par Value0.50
ISIN Number
Local : TH8569010003
Foreign : TH8569010011
NVDR : TH8569010R14
Dividend PolicyNot exceeding 50% of the profits after deducting corporate income tax and reserves in pursuant to the laws (with additional conditions)
Fiscal End31 Dec 2026
The person supervising accountingMiss Supaporn Kaewyai (Start Date 1 Jun 2022)
The person taking the highest responsibility in finance and accountingMiss Suwarin Konthong (Start Date 2 Dec 2019)
Capital Detail
Common Stock
Authorized Capital225,207,142.5
Paid-up Capital225,207,142.5
Preferred Shares
Authorized Capital-
Paid-up Capital-
Shares Detail
Common Stock
Listed Shares450,414,285
Paid-up Stock450,414,285Voting Right Ratio 1:1
Treasury Stock - : - - : -
Voting Stock minus Treasury Stock 31 Mar 2026 : 450,414,285 1 Apr 2026 : 450,414,285
Preferred Shares
Listed Shares-
Paid-up Stock-Voting Right Ratio -
Treasury Stock - : - - : -
Voting Stock minus Treasury Stock - : - - : -

Key Issues

Upcoming Event

Relate Stock Industry

Check out other big names from the same Industry DOD

symbol-https://s3.efinancethai.com/symbols-logo/DOD.pngDOD
efin Focus Metrics
Quarter 4/2025
Z-Score
3.32
2.16
3.30
Monitor C-Score
0.00
0.00
0.00
ICR
16.18
7.87
39.49
DSCR
0.00
1.10
2.41
EV/EBITDA
89,302.55
7.55
74,069.09
FCF Yield
0.00
47.31
3.93
FCF/Net Income
0.00
9.45
0.47
Net Debt/EBITDA
0.00
1.78
0.00
ROIC
7.22
4.98
10.44
Valuation Metrics
Last Price
1.80
1.96
2.26
P/E
12.46
13.57
11.83
P/BV
0.76
0.99
0.68
Dividend Yield
0.00
1.66
8.93
Financial Strength
D/E
0.21
0.58
0.28
Current Ratio
4.28
1.39
2.45
Net Profit Margin
10.12
4.33
6.49
ROE/ROA
1.69
0.94
1.17
Growth Metrics
Revenue Growth YoY
-7.16
14.50
10.09
Revenue Growth 3Y
78.75
94.07
16.89
Revenue Growth 3Y CAGR
21.36
24.73
5.34
Revenue per Share
0.00
0.00
0.00
EPS Growth
181.03
-148.19
106.97
EBITDA Growth
-191.38
305.78
48.43
5Y CAGR Total Return
-34.44
0.00
4.57
Market Cap (M.Bath)
729.67
901.69
708.64
Average Volume
25,086.10
1,086.00
1,095.15

efin Focus Metrics

Quarter 4/2025
Z-Score
Monitor C-Score
ICR
DSCR
EV/EBITDA
FCF Yield
FCF/Net Income
Net Debt/EBITDA
ROIC
Z-Score
xxx
xxx
xxx
Monitor C-Score
xxx
xxx
xxx
ICR
xxx
xxx
xxx
DSCR
xxx
xxx
xxx
EV/EBITDA
xxx
xxx
xxx
FCF Yield
xxx
xxx
xxx
FCF/Net Income
xxx
xxx
xxx
Net Debt/EBITDA
xxx
xxx
xxx
ROIC
xxx
xxx
xxx

Valuation Metrics

Last Price
1.80
1.96
2.26
P/E
12.46
13.57
11.83
P/BV
0.76
0.99
0.68
Dividend Yield
0.00
1.66
8.93

Financial Strength

D/E
0.21
0.58
0.28
Current Ratio
4.28
1.39
2.45
Net Profit Margin
10.12
4.33
6.49
ROE/ROA
1.69
0.94
1.17

Growth Metrics

Revenue Growth YoY
-7.16
14.50
10.09
Revenue Growth 3Y
78.75
94.07
16.89
Revenue Growth 3Y CAGR
21.36
24.73
5.34
Revenue per Share
0.00
0.00
0.00
EPS Growth
181.03
-148.19
106.97
EBITDA Growth
-191.38
305.78
48.43
5Y CAGR Total Return
-34.44
0.00
4.57
Market Cap (M.Bath)
729.67
901.69
708.64
Average Volume
25,086.10
1,086.00
1,095.15
Note
  • Calculated using adjusted prices.
  • Data is shown and calculated based on consolidated financial statements, presented as year-to-date quarterly figures. (If consolidated statements are unavailable, company-only statements are used.)
  • Financial data is updated quarterly within 7 business days after new statements are released.
  • Financial statement data reflects what listed companies submit for each period. Users should review the full financial statements for details, as some companies may revise comparative figures in the latest full version.
  • The list of companies included in the SETESG Index is announced together with other indices, based on the latest SET ESG Ratings results. Source: www.set.or.th (Copyright @ The Stock Exchange of Thailand).